Recommendations of the 4th Canadian Consensus Conference on the Diagnosis and Treatment of Dementia (CCCDTD4)
about
Anti-dementia medications: current prescriptions in clinical practice and new agents in progressFourth Canadian Consensus Conference on the Diagnosis and Treatment of Dementia: recommendations for family physiciansOlfactory groove and planum sphenoidale meningioma: Dementia masquerade.Alzheimer DiseaseThe appropriate use of neuroimaging in the diagnostic work-up of dementia: an evidence-based analysisThe "Rising Tide" of dementia in Canada: What does it mean for pharmacists and the people they care for?Guidelines for dementia or Parkinson's disease with depression or anxiety: a systematic review.Structured approach to patients with memory difficulties in family practiceAmyloid imaging for dementia in CanadaThe New Criteria for Alzheimer's Disease - Implications for GeriatriciansIdentification of potential or preclinical cognitive impairment and the implications of sophisticated screening with biomarkers and cognitive testing: does it really matter?Early-onset dementias: diagnostic and etiological considerations.Emerging concepts in geriatric psychiatry: an update on the canadian academy of geriatric psychiatry annual scientific meetingFluid biomarkers for diagnosing dementia: rationale and the Canadian Consensus on Diagnosis and Treatment of Dementia recommendations for Canadian physicians.Diagnosis and treatment of dementia: the fourth canadian consensus conference.Psychotropic and cognitive-enhancing medication use and its documentation in contemporary long-term care practice.Informing Understandings of Mild Cognitive Impairment for Older Adults: Implications From a Scoping Review.Clinical Utility of Amyloid PET Imaging in the Differential Diagnosis of Atypical Dementias and Its Impact on Caregivers.Tolerability of Cholinesterase Inhibitors: A Population-Based Study of Persistence, Adherence, and Switching.Therapeutic Strategies and Drug Development for Vascular Cognitive ImpairmentKynurenines and other novel therapeutic strategies in the treatment of dementia.Clinical Complexity and Use of Antipsychotics and Restraints in Long-Term Care Residents with Parkinson's Disease.I Have Something Interesting To Talk To You About: Speaking To Disagree, Agreeably.Antipsychotic Use in Dementia.Detecting and Managing Neuropsychiatric Symptoms in DementiaRe: Long-Term Efficacy and Toxicity of Cholinesterase Inhibitors in the Treatment of Alzheimer Disease.Antipsychotics and dementia in Canada: a retrospective cross-sectional study of four health sectors.For how long should we use symptomatic therapies to treat people with Alzheimer disease?Re: Long-Term Efficacy and Toxicity of Cholinesterase Inhibitors in the Treatment of Alzheimer Disease.A 2-year prospective cohort study of antidementia drug non-persistency in mild-to-moderate Alzheimer's disease in Europe : predictors of discontinuation and switch in the ICTUS study.Validation and diagnostic accuracy of predictive curves for age-associated longitudinal cognitive decline in older adults.Deprescribing antipsychotics for behavioural and psychological symptoms of dementia and insomnia: Evidence-based clinical practice guideline.Development and validation of a priori risk model for extensive white matter lesions in people age 65 years or older: the Dijon MRI study.Deconstructing Chronic Low Back Pain in the Older Adult-Step by Step Evidence and Expert-Based Recommendations for Evaluation and Treatment: Part XI: Dementia.An unusual ingestion in an older person: dentures.Pharmacological management of neuropsychiatric symptoms in patients with major neurocognitive disorders.Déprescription des antipsychotiques pour les symptômes comportementaux et psychologiques de la démence et l’insomnie: Guide de pratique clinique fondé sur des données probantes.Approche structurée en pratique familiale pour les patients ayant des problèmes de mémoire.Alzheimer's Biomarkers From Multiple Modalities Selectively Discriminate Clinical Status: Relative Importance of Salivary Metabolomics Panels, Genetic, Lifestyle, Cognitive, Functional Health and Demographic Risk Markers
P2860
Q26795400-8EFACEF6-EE6E-4CB2-9D0D-E0361D23F5CCQ27022269-6823C4C3-34D5-46D2-96D5-645256428A32Q33558505-EFA9D891-4C3B-44A4-9A6C-420F4F001128Q33562441-0A4E8E49-408B-46DE-B1E9-A820A8D0B551Q35109977-8AD2AE6E-2408-4514-8A6F-666DB5C2FCDAQ35932665-66E9DA9E-F65A-45BC-8AE6-9F3336A574A1Q36204169-9F6155A0-3806-4B8D-8B84-799BCD0F8EDFQ36680461-B465245A-03CD-4D6C-836F-888290AA39AFQ36905398-18363D12-9899-43FE-8D90-B2BB4242BD0CQ37041385-A26F329A-E56A-4099-B610-60F5A01501FFQ37043996-6C3BCFB1-92D9-4639-9419-0377521EB9D9Q37606162-A3A0293D-1060-40B3-908F-FCCC6050B7F5Q37613830-3E728A6D-2861-4A4B-94C3-5B918AE2F2CDQ37693146-5168D22E-1B0F-415F-8528-BE486B3FD7FDQ37693169-4B875262-D8ED-42C0-9279-64BB59D63CAAQ38182842-A6D9A8B2-4621-4F5F-9595-D82D3F3AF2F8Q38532673-B7D642EC-FCB4-4164-801F-59139ACBA0B6Q38877410-D88C31E4-1783-48D2-B80A-EF90CA60970CQ38990600-D99878A9-9294-49FF-AB2F-DC4116FC54C9Q39286909-C88DB4FB-6A62-4B4F-892C-E6E31E7DDD3FQ39315645-9D18785E-E57C-40F3-AB22-971424F840B6Q39334829-988C3951-CD2D-4A4E-B68F-E9AC966B23AEQ41532233-58899BA6-B48D-4B0B-9D59-B9495B422D62Q41827089-5B237E88-3B2F-49EE-898E-441F020A9E34Q42139411-36D21768-D1B9-4FD2-A632-1477C7B169C3Q42332050-AAA644DF-F110-4D37-9349-5389EB923D63Q42654539-DFBB11F8-F6C6-469A-A46E-4C01D7828051Q43117191-B86A64AA-C2AD-49F6-A79D-1E7D661E5BF7Q43293526-B884CCCB-F875-4748-8FAD-7D72EA89ECACQ44716353-AA0BB16D-A49D-4210-BFB3-56186F48AA6CQ47096390-269211E7-F265-4684-997E-C725BFF19E7BQ47557869-B0697E87-5358-4D19-9A94-387742E7FF42Q47569988-7FE74576-61F5-49A0-802A-482735524F56Q48028527-8568CA89-0176-48A8-95F9-535A4CDEA49CQ48353141-28293140-30A8-4DEF-B265-2AEC3C30DF9EQ49679750-19C96CC8-AB2E-4806-95F1-B6CE83FB9F84Q49874897-763A4B5C-37B8-4AA9-906D-CD51B692A0B8Q55545911-E9C792B5-667D-4A78-9430-29521A4CF81DQ58586046-4645DA73-1E5F-434C-9064-1D59EF6AAE17
P2860
Recommendations of the 4th Canadian Consensus Conference on the Diagnosis and Treatment of Dementia (CCCDTD4)
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Recommendations of the 4th Can ...... reatment of Dementia (CCCDTD4)
@ast
Recommendations of the 4th Can ...... reatment of Dementia (CCCDTD4)
@en
type
label
Recommendations of the 4th Can ...... reatment of Dementia (CCCDTD4)
@ast
Recommendations of the 4th Can ...... reatment of Dementia (CCCDTD4)
@en
prefLabel
Recommendations of the 4th Can ...... reatment of Dementia (CCCDTD4)
@ast
Recommendations of the 4th Can ...... reatment of Dementia (CCCDTD4)
@en
P2093
P2860
P356
P1476
Recommendations of the 4th Can ...... reatment of Dementia (CCCDTD4)
@en
P2093
Christopher Patterson
Jean-Paul Soucy
Kenneth Rockwood
Michael Gordon
Nathan Herrmann
Serge Gauthier
P2860
P304
P356
10.5770/CGJ.15.49
P577
2012-12-04T00:00:00Z